Literature DB >> 6360874

Hypertension detection and follow-up program. Baseline electrocardiographic characteristics of the hypertensive participants.

R J Prineas, C H Castle, J D Curb, R Harrist, A Lewin, J Stamler.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6360874     DOI: 10.1161/01.hyp.5.6_pt_2.iv160

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  5 in total

1.  United States national prevalence of electrocardiographic abnormalities in black and white middle-age (45- to 64-Year) and older (≥65-Year) adults (from the Reasons for Geographic and Racial Differences in Stroke Study).

Authors:  Ronald J Prineas; Anh Le; Elsayed Z Soliman; Zhu-Ming Zhang; Virginia J Howard; Yechiam Ostchega; George Howard
Journal:  Am J Cardiol       Date:  2012-01-14       Impact factor: 2.778

2.  Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry).

Authors:  Donald M Lloyd-Jones; Alan R Dyer; Renwei Wang; Martha L Daviglus; Philip Greenland
Journal:  Am J Cardiol       Date:  2006-12-29       Impact factor: 2.778

3.  Framingham risk score and prediction of coronary heart disease death in young men.

Authors:  Jarett D Berry; Donald M Lloyd-Jones; Daniel B Garside; Philip Greenland
Journal:  Am Heart J       Date:  2007-07       Impact factor: 4.749

4.  Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II.

Authors:  Fereidoun Azizi; Arash Ghanbarian; Amir Abbas Momenan; Farzad Hadaegh; Parvin Mirmiran; Mehdi Hedayati; Yadollah Mehrabi; Saleh Zahedi-Asl
Journal:  Trials       Date:  2009-01-25       Impact factor: 2.279

Review 5.  Electrocardiographic left ventricular hypertrophy with strain pattern: prevalence, mechanisms and prognostic implications.

Authors:  O S Ogah; O O Oladapo; A A Adebiyi; A K Adebayo; A Aje; D B Ojji; B L Salako; A O Falase
Journal:  Cardiovasc J Afr       Date:  2008 Jan-Feb       Impact factor: 1.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.